WALL STREET JOURNAL COVERS EXSIGHT

WALL STREET JOURNAL COVERS NEW CROP OF VENTURE FIRMS INCLUDING EXSIGHT

New crop of venture firms takes aim at individual disease areas. Some venture capitalists are raising funds focused on cancer or other specific medical fields

"Founders of disease-specific funds say it is possible to build a diversified portfolio within a single sector. In ophthalmology, there are distinct diseases affecting the front and back of the eyes, and a variety of drugs and medical devices are being developed to treat them, said James Murray, co-founder and partner of ExSight Ventures, a vision-focused firm based in New York.
“Within one small area of the body, you have the opportunity to invest in different sectors that have different risk profiles,” Mr. Murray said. ​

ExSight Ventures was mentioned alongside other specialized venture firms in an article by Brian Gormley in the Wall Street Journal.
The article covers the "long-running trend toward specialization in venture capital."
Read the article on WSJ.com.